Mouse study links cannabis compound NCT to gut-barrier and immune effects

N-Trans Caffeoyltyramine Alleviates Ulcerative Colitis by Targeting FXR to Promote Epithelial Barrier Protection and M2 Macrophage Polarization.

Phytotherapy research : PTR • • Highly Relevant
🤖

AI Summary

This study asked whether two compounds found in Cannabis sativa—N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT)—could ease ulcerative colitis. Researchers compared them in a mouse model of acute colitis and examined their effects in colonic epithelial cells and macrophages. The abstract reports that NCT was more effective than NFT at alleviating acute colitis in the mice.

The proposed explanation is that NCT helps preserve the intestinal lining by increasing tight junction proteins and promotes a protective M2 macrophage state. The nuclear receptor FXR contributed to both effects in genetic loss-of-function experiments. These are preclinical findings: the abstract does not establish that NCT treats ulcerative colitis in people, and it gives no quantitative results. This is an abstract-based summary; the findings support further preclinical study, not a clinical treatment conclusion.

💡 Key Findings

1
In a mouse model of acute ulcerative colitis, NCT alleviated disease more effectively than NFT, according to the abstract.
Moderate
55%
2
NCT was associated with improved intestinal barrier integrity through increased tight junction proteins.
Moderate
55%
3
NCT promoted protective M2 macrophage polarization, with FXR contributing to this effect and to barrier enhancement.
Moderate
55%

📄 Original Abstract

BACKGROUND AND AIM: Ulcerative colitis (UC) remains a clinical challenge owing to the complex pathogenesis and lack of curative therapies. Although Cannabis sativa has been associated with alleviating inflammatory bowel disease, the specific active constituents and underlying mechanisms remain poorly defined. The present study aimed to systematically evaluate the anti-UC effects and mechanisms of two structurally related compounds from C. sativa extracts, N-trans caffeoyltyramine (NCT), and N-trans feruloyltyramine (NFT). EXPERIMENTAL PROCEDURE: We compared the therapeutic efficacy of NCT and NFT in an acute UC mice model, and investigated the underlying mechanisms using both colonic epithelial cells and macrophages. To validate the involvement of the nuclear receptor FXR, we performed genetic loss-of-function approaches to assess the impact on epithelial barrier integrity and macrophage polarization. KEY RESULTS: NCT is proven superior to NFT in alleviating acute UC. Remarkably, NCT exerts therapeutic efficacy by coordinating two pivotal aspects of UC pathogenesis. It improves tight junction structural integrity through upregulation of tight junction proteins while simultaneously promoting a protective M2 macrophage polarization. Mechanistically, FXR was identified as a key mediator of the effects of NCT, contributing to both barrier enhancement and macrophage phenotype switching. CONCLUSIONS AND IMPLICATIONS: The results provide a molecular rationale for the anti-UC activity of C. sativa and suggest that NCT alleviates UC, at least in part through FXR-mediated pathways. These findings support further preclinical development of NCT as a potential therapeutic candidate for UC.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.